Anti-ILF2 antibodies are used in the immunodetection of the protein interleukin enhancer binding factor 2. In humans, the canonical protein has a reported length of 390 amino acid residues and a mass of 43.1 kDa. Its subcellular localization is in the nucleus and cytoplasm. It is notably widely expressed in many tissue types. ILF2 is reported to be a chromatin-interacting protein that forms a stable heterodimer with interleukin enhancer-binding factor 3/ILF3 and plays a role in several biological processes including transcription, innate immunity or cell growth. Synonyms for this target antigen include PRO3063, interleukin enhancer binding factor 2, 45kD, interleukin enhancer binding factor 2, 45kDa, nuclear factor of activated T-cells, 45-kDa, and NF45. ILF2 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. A number of ILF2 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. Immunofluorescence and Immunohistochemistry are also common applications.